Catalyst Wire Dossier Catalyst Wire Dossier

Alferon LDO

Interferon alfa · AIM ImmunoTech Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alferon LDO, covering 2013-09-04 to 2013-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects [Phase 2]

See pricing